These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 17070359

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
    Walz J, Haese A, Scattoni V, Steuber T, Chun FK, Briganti A, Montorsi F, Graefen M, Huland H, Karakiewicz PI.
    Cancer; 2008 Nov 15; 113(10):2695-703. PubMed ID: 18853417
    [Abstract] [Full Text] [Related]

  • 23. Lowering the PSA threshold for prostate biopsy from 4 to 2.5 ng/ml: influence on cancer characteristics and number of men needed to biopt.
    Müntener M, Kunz U, Eichler K, Puhan M, Schmid DM, Sulser T, Strebel RT.
    Urol Int; 2010 Nov 15; 84(2):141-6. PubMed ID: 20215816
    [Abstract] [Full Text] [Related]

  • 24. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection.
    Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ.
    J Urol; 2000 Aug 15; 164(2):388-92. PubMed ID: 10893592
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Is there a relationship between prostate volume and Gleason score?
    Mir MC, Planas J, Raventos CX, de Torres IM, Trilla E, Cecchini L, Orsola A, Morote J.
    BJU Int; 2008 Aug 05; 102(5):563-5. PubMed ID: 18476971
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.
    Suzuki H, Akakura K, Igarashi T, Ueda T, Ito H, Watanabe M, Nomura F, Ochiai T, Shimada H.
    J Urol; 2004 Jan 05; 171(1):182-6. PubMed ID: 14665872
    [Abstract] [Full Text] [Related]

  • 31. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L, Jones JS, Zippe CD, Reuther AM, Klein E, Zhou M, Magi-Galluzzi C.
    BJU Int; 2007 Apr 05; 99(4):770-4. PubMed ID: 17233800
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M, Varedi P, Hosseini SJ, Asgari M, Shakiba M.
    Urol J; 2009 Apr 05; 6(3):182-8. PubMed ID: 19711272
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of precursor prostate-specific antigen isoform ratios in the detection of prostate cancer.
    Naya Y, Fritsche HA, Bhadkamkar VA, Mikolajczyk SD, Rittenhouse HG, Babaian RJ.
    Urol Oncol; 2005 Apr 05; 23(1):16-21. PubMed ID: 15885578
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Value of free PSA/total PSA ratio in therapeutic decisions in the case of a single positive biopsy of the prostate].
    Huyghe E, Soulie M, Tollon C, Escourrou G, Pontonnier F, Plante P.
    Prog Urol; 1999 Apr 05; 9(2):281-7. PubMed ID: 10370952
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.